Protective Effects of Nicotinamide Adenine Dinucleotide and Related Precursors in Alzheimer’s Disease: A Systematic Review of Preclinical Studies
Data from preclinical studies propose nicotinamide adenine dinucleotide (NAD + ) as a neuroprotective and bioenergetics stimulant agent to treat Alzheimer’s disease (AD); however, there seems to be inconsistency between behavioral and molecular outcomes. We performed this systematic review to provid...
Saved in:
Published in | Journal of molecular neuroscience Vol. 71; no. 7; pp. 1425 - 1435 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
New York
Springer US
01.07.2021
Springer Nature B.V |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!